Pharmacologic therapies in endometriosis: a systematic review.
about
Medical treatments for endometriosis-associated pelvic painMolecular network analysis of endometriosis reveals a role for c-Jun-regulated macrophage activation.Peripheral changes in endometriosis-associated pain.Compatibility of a novel thrombospondin-1 analog with fertility and pregnancy in a xenograft mouse model of endometriosis.Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program.Interplay between Endometriosis and Pregnancy in a Mouse Model.The combination of N-acetyl cysteine, alpha-lipoic acid, and bromelain shows high anti-inflammatory properties in novel in vivo and in vitro models of endometriosis.Inhibition of Hyaluronic Acid Synthesis Suppresses Angiogenesis in Developing Endometriotic Lesions.The expression of histone deacetylase 1, but not other class I histone deacetylases, is significantly increased in endometriosis.Melatonin treatment results in regression of endometriotic lesions in an ooferectomized rat endometriosis model.Dysregulated cell mechanical properties of endometrial stromal cells from endometriosis patients.Effects of U0126 and MK2206 on cell growth and re-growth of endometriotic stromal cells grown on substrates of varying stiffnessTowards an understanding of the molecular mechanism of endometriosis: unbalancing epithelial-stromal genetic conflict.Endometrial adult/progenitor stem cells: pathogenetic theory and new antiangiogenic approach for endometriosis therapy.A comparison of progestogens or oral contraceptives and gonadotropin-releasing hormone agonists for the treatment of endometriosis: a systematic review.Endometriosis: a role for stem cells.Experimental treatments of endometriosis.A systematic review on endometriosis during pregnancy: diagnosis, misdiagnosis, complications and outcomes.The oil-resin of the tropical rainforest tree Copaifera langsdorffii reduces cell viability, changes cell morphology and induces cell death in human endometriotic stromal cultures.Antifibrotic properties of epigallocatechin-3-gallate in endometriosis.Validation of a score to guide endometriosis therapy for the non-specialized gynecologist.Naringenin induces mitochondria-mediated apoptosis and endoplasmic reticulum stress by regulating MAPK and AKT signal transduction pathways in endometriosis cells.The Protective Role of Dexpanthenol on the Endometrial Implants in an Experimentally Induced Rat Endometriosis Model.Androgens Upregulate Endometrial Epithelial Progesterone Receptor Expression: Potential Implications for Endometriosis.Effect of alpha-lipoic acid on endometrial implants in an experimental rat model.Efficacy, safety and tolerability of the CCR1 antagonist BAY 86-5047 for the treatment of endometriosis-associated pelvic pain: a randomized controlled trial.In vitro and in vivo effects of MK2206 and chloroquine combination therapy on endometriosis: Autophagy may be required for regrowth of endometriosis.Evaluation of peritoneal endometriosis treatment using intralesional acetylsalicylic acid injection in rabbits.The effects of levamisole on experimental endometriosis: a randomized controlled trial in a rat model.Comparison of efficacy of bromocriptine and cabergoline to GnRH agonist in a rat endometriosis model.Cathepsin Protease Inhibition Reduces Endometriosis Lesion Establishment.Response to the paper entitled "dopamine mobilizes mesenchymal progenitor cells through D2-class receptors and their PI3K/AKT pathway" by Mirones, et al., 2014.Phytochemical analyses and effects of Alchemilla mollis (Buser) Rothm. and Alchemilla persica Rothm. in rat endometriosis modelClinical evaluation and management of endometriosis: guideline for Korean patients from Korean Society of EndometriosisNew insights on the pathogenesis of endometriosis and novel non-surgical therapies
P2860
Q26991844-B7067BB2-9C1D-4C48-AF65-405F468584E5Q33987534-D1306005-4EB6-46F4-B145-FF23F850C84DQ34421299-5918A24E-E86A-4DC9-89D0-AC17C9AE1BCAQ35219893-72D7C0E6-A70C-4665-BAE6-0DFEA60DB078Q35491233-F057D51F-6B61-46CD-AF12-B22BB820CFC9Q35542770-93CD5408-6012-48E9-A42C-08D305791885Q35557263-8F96C8E3-E4AF-4F3C-8604-410073009CEAQ35971408-D978E1E0-18B0-48D7-85DA-03AE4C8B4CB0Q37280160-A03E330F-4179-46F9-B29C-A45CA863524BQ37437444-43A00458-E3B5-4164-BF14-01C5F575F3C0Q37587369-DED50CB6-B45B-490C-BAC3-6BFAA7E0118CQ37652650-90A5057F-AA14-4269-9822-1CB35175597CQ38133821-5902A45B-6023-4080-9DC7-AB93138E9839Q38137804-DEDB0581-363A-4FFD-A26E-1EC66329D14AQ38192713-BF8B65CC-7021-4E55-B03C-382FB96A01BBQ38315216-25ED256F-3F1B-42CA-BA07-DAE3E309D2A4Q38575273-05C469D1-9851-4AF8-836B-D39174DC18B3Q38602857-9B68A781-2E29-4953-ADD3-7C79B1137620Q39064220-8AA43ADD-1EA0-4154-B314-D924B712AB51Q39184401-97FB7F7F-1720-4E9E-988F-A2DBEAC0CD5FQ40638679-D93D5940-84A4-4E61-BE59-F639E824DD6AQ46264809-1816F585-D9B8-4112-B498-7AACA1B26BC4Q46531279-2B26C0B0-D94D-4F10-9109-0DD589B3C4D6Q47824474-2842187F-AD96-47E7-BB26-E53D00C8A331Q48249112-7BB3759A-4D48-48E3-8AA7-2ADCC8E7FFFCQ48268499-F9904213-2A64-479D-B938-2E59A751F93AQ49849111-ED8C4BA5-59B1-4ED8-8A29-C275B47576ACQ50899458-6FA625B8-D2E9-4306-9EA2-433505A093AAQ50956324-035491C8-E5AB-40C8-BF34-13EB4C5DBB92Q51103462-86E75378-EA23-4EA4-BD39-10A8B13CF89FQ51679600-5CAAF7A1-7646-4A64-AF27-3DA4F581E4C9Q53023258-F8FFCB20-114D-4BEA-93CC-61F99811DB82Q58277905-BFD6F385-D33A-4870-A435-CCAE4792A64DQ58758995-EF11CA77-E1CE-4FCB-A015-172F252A6769Q58799203-73C9F507-C6DD-491A-917C-CF4BBDF4846B
P2860
Pharmacologic therapies in endometriosis: a systematic review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacologic therapies in endometriosis: a systematic review.
@en
type
label
Pharmacologic therapies in endometriosis: a systematic review.
@en
prefLabel
Pharmacologic therapies in endometriosis: a systematic review.
@en
P1476
Pharmacologic therapies in endometriosis: a systematic review
@en
P2093
Alicia Martínez-Varea
Juan José Hidalgo-Mora
P304
P356
10.1016/J.FERTNSTERT.2012.07.1120
P407
P577
2012-09-01T00:00:00Z